Disopyramide and Tolbutamide: Interaction Details
- Disopyramide
- NorpaceNorpace CR
- Tolbutamide
- Orinase
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Disopyramide and Tolbutamide interaction:
Disopyramide
- Norpace
- Norpace CR
Tolbutamide
- Orinase
We don't have a drug information page for Tolbutamide yet. Have a question about Tolbutamide? Ask a pharmacist, free →
What Happens When You Take Disopyramide With Tolbutamide
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When disopyramide is given together with a sulfonylurea, the resulting rise in insulin secretion can lead to severe hypoglycemia. Disopyramide is thought to cause hypoglycemia by blocking K(ATP) channels on pancreatic beta cells, which depolarizes the beta cell and thereby enhances insulin release.
Sulfonylureas likewise act as of K(ATP) channels. Each drug alone is believed to produce only partial of these channels (roughly 50% to 60%), yet their inhibitory effects add together when the two are combined.
The proposed explanation is that giving both K(ATP) channel inhibitors at the same time blocks the channels almost entirely (roughly 95%), so the beta cell membrane remains continuously depolarized, insulin secretion is sustained, and hypoglycemia follows. Caution is warranted when disopyramide is combined with sulfonylureas or other K(ATP) channel inhibitors.1
The Disopyramide and Tolbutamide Interaction, Explained
Disopyramide (Norpace) helps keep your heart rhythm steady. Tolbutamide helps lower your blood sugar by telling your pancreas to release more insulin. Here is the catch: disopyramide can also nudge your pancreas to release insulin. When you take both, they add together, and your blood sugar could drop too low. This is called .
Watch for shakiness, sweating, a fast heartbeat, hunger, confusion, or feeling dizzy. The good news: your care team can manage this. They may check your blood sugar more closely and adjust your doses for you. Keep taking your medicines as prescribed, and talk with your pharmacist or doctor about any questions or symptoms.
interaction (), major severity, probable evidence; onset unspecified.
- Mechanism: Disopyramide inhibits pancreatic beta-cell K(ATP) channels (about 50% to 60%), as does tolbutamide. Combined is proposed to approach about 95%, causing sustained beta-cell depolarization, continuous insulin secretion, and potentially profound . Not a PK (-mediated) interaction.
- Risk factors to consider: elderly, or impairment, poor oral intake.
- Management: Use with caution. Monitor blood glucose closely, particularly at initiation or dose changes of either agent; individualize sulfonylurea dosing as needed. Counsel patients on hypoglycemia recognition and treatment. Disopyramide also carries proarrhythmic risk, so coordinate changes with the prescriber.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Disopyramide and Tolbutamide Interact
The likely mechanism
Unknown
“Unknown” here means the studies and labels behind this record do not say how the interaction happens. It does not mean the interaction is unlikely.
When two medicines can each cause the same effect, here changes in blood sugar, taking them together can add to it. That is often the reason for an interaction like this one, though the sources do not confirm it for this pair.
How to Manage the Disopyramide and Tolbutamide Interaction
Taking disopyramide and tolbutamide together calls for caution because your blood sugar may drop lower than expected. Your care team can manage this by:
- Monitoring your blood sugar more closely, especially when either medicine is started or changed
- Adjusting and individualizing your doses if needed
What you can do:
- Keep taking both medicines exactly as prescribed
- Learn the signs of low blood sugar (shaking, sweating, confusion, hunger) and tell your pharmacist or doctor if they happen
- Ask your pharmacist or prescriber how and when to check your blood sugar
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Disopyramide or Tolbutamide need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Mechanism of disopyramide-induced hypoglycaemia in a patient with Type 2 diabetes
Two weeks after disopyramide 300 mg daily was added to the regimen of a 62-year-old woman receiving glimepiride 0.5 mg daily, she developed a severe hypoglycemic episode that necessitated hospitalization. When disopyramide was initiated, she had been taking glimepiride for 4 months, with an HbA1c of 7.8% to 8.1% and no prior hypoglycemic episodes.
At hospital admission, her blood sugar was 1.1 mmol/L, her HbA1c was 5.8%, and her disopyramide concentration was 3.7 mcg/mL; and function were within normal limits. Her blood glucose returned to normal one hour after an IV injection of 50% glucose.
Disopyramide was stopped, and glimepiride 0.5 mg daily was continued. After two months, the glimepiride dose was raised to 1 mg daily, and at the 6-month follow-up visit she reported no additional hypoglycemic episodes.1
Disopyramide and Tolbutamide: Common Questions
How serious is the Disopyramide and Tolbutamide interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Disopyramide and Tolbutamide interaction managed?
Taking disopyramide and tolbutamide together calls for caution because your blood sugar may drop lower than expected. Your care team can manage this by: Monitoring your blood sugar more closely, especially when either medicine is started or changed Adjusting and individualizing your doses if needed What you can do: Keep taking both medicines exactly as prescribed Learn the signs of low blood sugar… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Disopyramide and Tolbutamide Interaction
Ask in your own words about taking Disopyramide and Tolbutamide together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Negishi M, Shimomura K, Proks P, et al: Mechanism of disopyramide-induced hypoglycaemia in a patient with Type 2 diabetes. Diabet Med 2009; 26(1):76-78. DOI
Other Serious Interactions of Disopyramide and Tolbutamide
Also serious with Disopyramide
- DronedaroneContraindicated
- FingolimodContraindicated
- ItraconazoleContraindicated
- LevoketoconazoleContraindicated
Also serious with Tolbutamide
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Tolbutamide
- Activated CharcoalMajor
- Siberian CockleburMajor
- ChromiumModerate
- GingerModerate
- TurmericModerate
- InositolModerate
- AshwagandhaModerate
- Black PepperModerate
- + 299 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.